Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

New Century Healthcare to Stage $100 Million Hong Kong IPO

publication date: Dec 30, 2016
New Century Healthcare, which operates three pediatric clinics and recently acquired a women's hospital in Beijing, was approved to stage a $100 million IPO on the Hong Kong exchange. The company will use 40% of the proceeds to buy one hospital and five clinics in tier-one cities. Another 20% of the funds will be allocated to upgrading its existing clinics, along with opening a new hospital and two clinics in other tier-one cities such as Shanghai and Guangzhou. The IPO is expected to take place in January 2017. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital